CD4 and neoplasm: A comparison of a panel of adjuvants on antitumor responses upon peptide vaccination in tumor mouse models showed that CPG-ODNs and PolyI:C promoted the expansion of antigen-specific CD8 and CD4 effector T cells compared to QuilA and Imiquimod that decreased the effector T cells [55].